Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injections plus isometric exercises versus usual NHG care for shoulder complaints
NL-OMON28162Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of triamcinolone acetonide and lidocaine in rotator cuff tendinitis and tendinitis (2 arms), sponsored by Erasmus MC. Primary endpoint: Primary pain outcome. Started Sep 2007; status: recruiting.
02
Drugs
triamcinolone acetonidelidocaine
03
Conditions
rotator cuff tendinitistendinitis
Beyond the preview
Go deeper on NL-OMON28162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28162.